DocMorris AG (XSWX:DOCM) GF Score : 60/100 (As of Apr. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is DocMorris AG GF Score?

DocMorris AG has the GF Score of 60, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 2/10
3. Growth Rank : 6/10
4. GF Value Rank : 1/10
5. Momentum Rank : 6/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes DocMorris AG might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of DocMorris AG's GF Score

For the Pharmaceutical Retailers subindustry, DocMorris AG's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DocMorris AG's GF Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's GF Score distribution charts can be found below:

* The bar in red indicates where DocMorris AG's GF Score falls into.

DocMorris AG (XSWX:DOCM) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

DocMorris AG GF Score Related Terms

Thank you for viewing the detailed overview of DocMorris AG's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

DocMorris AG (XSWX:DOCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocMorris AG (XSWX:DOCM) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

ZRSEF:USA DOCMz:UK

Address

Walzmuhlestrasse 60, Frauenfeld, CHE, 8500

Website

https://www.zurrosegroup.com

DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Switzerland, Germany, and Europe. The operating segment in Switzerland comprises the wholesale business of supplying medical products to Swiss medical practitioners and the retail business that is focused on providing end consumers with drugs and health products from Zur Rose. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.

DocMorris AG (XSWX:DOCM) Headlines

No Headlines